L'action de Moderna s'envole de 90% après le succès d'un essai de vaccin anticancéreux de phase 3
Tap title to read story
0:00 / 1:23
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story